Claims for Patent: 7,439,057

Summary for Patent: 7,439,057

Title:	Convective flow tissue assembly
Abstract:	The present invention provides for an improved in vitro tissue assembly system and related methods that includes and uses a bioreactor, a porous mandrel disposed in the bioreactor, and components that provide for the circulation of culture media and cell suspensions within the bioreactor and through the porous mandrel. The circulation of the culture media and cell suspensions within the bioreactor produces a radial, convective flow and drag forces that result in the deposition of cells on the mandrel to form a tissue construct. Upon completion of the culture and tissue formation process, the tissue construct may be removed from the mandrel for subsequent in vivo use.
Inventor(s):	Frangos; John A. (La Jolla, CA), Sobolewski; Peter (San Diego, CA)
Assignee:	La Jolla Bioengineering Institute (La Jolla, CA)
Application Number:	10/991,079
Patent Claims:	1. A method for making an engineered tissue construct, comprising the steps of: providing a chamber comprising an interior volume, at least one inlet, and at least one outlet; providing a mandrel comprising a porous surface that defines an interior volume, the mandrel being disposed within the chamber, the interior volume of the mandrel communicating with the at least one outlet; infusing culture media through the at least one inlet into the interior volume of the chamber; infusing a suspension of cells into the interior volume of the chamber; aspirating culture media from the at least one outlet, wherein culture media passes from the interior volume of the chamber through the pores of the mandrel to the interior volume of the mandrel, and cells are deposited on the surface of the mandrel; removing the mandrel from the chamber after a tissue construct is formed on the mandrel; removing the tissue construct from the mandrel; inserting the tissue construct into the chamber; reversing the flow of culture media within the interior volume of the chamber; and infusing endothelial cells into the interior volume of the chamber, wherein the endothelial cells pass into the tissue construct and are deposited on an inner surface of the tissue construct. 2. The method of claim 1, wherein the cells deposited on the surface of the mandrel are maintained so that the cells secrete extracellular matrix and form a tissue. 3. The method of claim 2, wherein the tissue is formed in the shape of the mandrel. 4. The method of claim 1, wherein the steps of aspirating culture media from the at least one outlet and infusing culture media through the at least one inlet are continued until a continuous cellular membrane is formed around the mandrel. 5. The method of claim 4, wherein the mandrel is a elongate tubular member having a first end, a second end, and a lumen therebetween, the lumen being in fluid communication with the at least one outlet, and wherein a cellular membrane is formed around the mandrel in the shape of a vessel. 6. The method of claim 4, wherein the suspension of cells is a first suspension of cells, the method further comprising infusing a second suspension of cells of a different cell type from the first suspension of cells into the culture media to form a layered tissue construct. 7. The method of claim 6, wherein the first suspension of cells comprises smooth muscle cells and the second suspension of cells comprises fibroblasts. 8. The method of claim 6, wherein the first suspension of cells comprises epithelia cells and the second suspension of cells comprises smooth muscle cells. 9. The method of claim 6, wherein the first suspension of cells comprises chondrocytes and the second suspension of cells comprises fibroblasts. 10. The method of claim 6, wherein the first suspension of cells comprises fibroblasts and the second suspension of cells comprises keratynocytes. 11. The method of claim 6, wherein the first suspension of cells comprises endothelial cells and the second suspension of cells comprises hepatocytes. 12. The method of claim 1, wherein the suspension of cells comprises skeletal muscle cells. 13. The method of claim 1, wherein the suspension of cells comprises cardiac muscle cells. 14. A method for making an engineered tissue construct, comprising the steps of: infusing a culture media into an interior volume of a chamber comprising the interior volume, an inlet, and an outlet; infusing a suspension of cells into the interior volume of the chamber; aspirating culture media from the interior volume, wherein a mandrel having an interior volume and a surface with a plurality of pores is located within the interior volume of the chamber, and culture media passes from the interior volume of the chamber through the pores of the mandrel to the interior volume of the mandrel and the cells are deposited on the surface of the mandrel; and removing from the mandrel a tissue construct formed by the cells deposited on the surface of the mandrel by applying a reverse pressure gradient to the mandrel. 15. The method of claim 14, wherein infusing a suspension of cells comprises: infusing a plurality of suspensions of cells into the interior volume of the chamber, each suspension of cells comprising a distinct cell type. 16. The method of claim 15, wherein each suspension of cells is infused sequentially into the interior volume of the chamber. 17. A method for making an engineered tissue construct, comprising the steps of: infusing a culture media into an interior volume of a chamber comprising the interior volume, an inlet, and an outlet; infusing a suspension of cells into the interior volume of the chamber; aspirating culture media from the interior volume, wherein a mandrel having an interior volume and a surface with a plurality of pores is located within the interior volume of the chamber, and culture media passes from the interior volume of the chamber through the pores of the mandrel to the interior volume of the mandrel and the cells are deposited on the surface of the mandrel; and removing from the mandrel a tissue construct formed by the cells deposited on the surface of the mandrel by applying a collagenase infusion on the mandrel. 18. A method for making an engineered tissue construct, comprising the steps of: infusing a culture media into an interior volume of a chamber comprising the interior volume, an inlet, and an outlet; infusing a suspension of cells into the interior volume of the chamber; aspirating culture media from the interior volume, wherein a mandrel having an interior volume and a surface with a plurality of pores is located within the interior volume of the chamber, and culture media passes from the interior volume of the chamber through the pores of the mandrel to the interior volume of the mandrel and the cells are deposited on the surface of the mandrel; removing the mandrel from the chamber after a tissue construct is formed on the mandrel; removing the tissue construct from the mandrel; inserting the tissue construct into the chamber; reversing the flow of culture media within the interior volume of the chamber; and infusing endothelial cells into the interior volume of the chamber, wherein the endothelial cells pass into tissue construct and are deposited on an inner surface of the tissue construct.

Details for Patent 7,439,057

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2039-03-29